Josep Tabernero MD a, Paulo M Hoff MD b, Prof Lin Shen MD c, Atsushi, Ohtsu MD d, Manish A Shah MD e, Karen Cheng PharmD f, Chunyan Song MD f, Haiyan Wu PhD g, Jennifer Eng-Wong MD f, Katherine Kim MPH f, Prof Yoon-Koo Kang MDh,*
aVall d'Hebron University Hospital and Institute of Oncology, Universitat Autonoma de Barcelona, Centro de Investigacion Biomedica en Red Cancer, Barcelona, Spain
bInstituto do Cancer de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
cKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China
dDepartment of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
eMeyer Cancer Center at Weill Cornell Medical College, Medical Oncology/Solid Tumor Program, New York, NY, USA
fProduct Development Oncology, Genentech Inc, South San Francisco, CA, USA
gBiostatistics, Biometrics, Roche Holding Ltd, Shanghai, China
hDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
*Correspondence to: Prof Yoon-Koo Kang, Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505 South Korea